Sign in Subscribe

Archive

A collection of 105 issues

Latest

BPC 157 for Sale: Sourcing Responsibly in Australia 2026

You've probably landed on BPC 157 for sale after comparing supplier pages, checking lab files, and trying to work out which listings are suitable for research procurement in Australia. The first issue isn't price, it's whether the product can be treated as a controlled,

Melanotan 1 Australia: A Research Procurement Guide

Melanotan 1, also known as afamelanotide, is treated by the TGA as a Schedule 4 prescription-only substance, isn't approved as a tanning agent in Australia, and should be supplied to laboratories only for research under documented verification workflows. For Australian procurement teams, that means identity, batch traceability,

Muscle Peptides Australia: Research Guide for Labs

In 2022, 65.8% of Australian adults were overweight or obese, making metabolic and muscle-peptide research a significant national research topic. That figure represents population health context, not proof that any particular research peptide is safe, effective, approved or suitable for human use. For laboratories and procurement teams, muscle

Bpc 157 Peptides: Research and Regulation in Australia

BPC 157 is an experimental preclinical research compound with no established human clinical evidence. It isn't included in the Australian Register of Therapeutic Goods and has been classified as a Schedule 4 prescription-only substance in Australia since 1 June 2024. An Australian laboratory manager comparing suppliers can

Peptide Mg/ml Calculation: A Practical Research Guide

Concentration, C, equals mass, m, divided by final volume, V. A measured 10 mg quantity brought to a verified final volume of 2.0 mL produces 5.0 mg/mL, and a 1.5 mg research aliquot at that concentration corresponds to 0.30 mL, provided the units are compatible.

How to Reconstitute Peptides: A Lab Protocol Guide

A lyophilised peptide vial has arrived, the study protocol is waiting, and the next decision is more important than just adding water. The volume you choose determines the stock concentration, which affects assay preparation, serial dilutions, pipetting practicality and how clearly the final record can be audited. Peptide reconstitution is

MOTS-c Australia: A Researcher's Reference Guide

A question sits underneath much of the online discussion about MOTS-c Australia: are researchers evaluating a defined mitochondrial signalling reagent, or are they being asked to accept therapeutic conclusions that the evidence cannot yet support? For an Australian laboratory, the answer starts with identity, not marketing. MOTS-c is

Peptides for Weight Loss: A Researcher's Guide

The most popular advice about peptides for weight loss often begins with efficacy and ends with dosing. In Australia, that order is backwards. The first question for a researcher, procurement team or laboratory manager is whether the material is a TGA-approved prescription medicine, an unapproved therapeutic good, or a

Tesamorelin Australia: Research, Regulation and Lab Sourcing

The most popular advice about tesamorelin in Australia tends to begin with availability, delivery speed or advertised vial formats. That order of priorities is backwards for a laboratory. The first question is whether the compound is registered on the Australian Register of Therapeutic Goods, what the supplier is offering, and

Semax Australia: A Research Buyer's Practical Guide

Semax in Australia sits in a narrow but active research market, not a mainstream therapeutic one. One Australia-focused price comparison tracked 27 suppliers, 33 listings, and 31 shown in stock, with a reported range from A$4.16/mg to A$13.00/mg and a median of A$